Cargando…

Niacin for phosphate control: A case of David versus Goliath

Detalles Bibliográficos
Autor principal:	Sampathkumar, K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964681/ https://www.ncbi.nlm.nih.gov/pubmed/27510758 http://dx.doi.org/10.4103/0971-4065.161029

Ejemplares similares

Commentary: Epsilon-aminocaproic acid versus tranexamic acid, the David and Goliath of antifibrinolytics
por: Faraoni, David
Publicado: (2020)

Alcohol marketing versus public health: David and Goliath?
por: Madden, Mary, et al.
Publicado: (2021)

David and Goliath: chemical perturbation of eukaryotes by bacteria
por: Ho, Louis K., et al.
Publicado: (2015)

David Versus Goliath: The Clinical Consequences of an Influenza A Viral Infection in an Unvaccinated Patient
por: Harmon, Taylor S, et al.
Publicado: (2019)

Fr580 THE MICROBIOME AND SARS-COV-2: DAVID VERSUS A TINY GOLIATH
por: Hazan, Sabine, et al.
Publicado: (2021)

Obscurins: Goliaths and Davids Take over Non-Muscle Tissues
por: Ackermann, Maegen A., et al.
Publicado: (2014)

David and Goliath - Employer Takes on Health Care Cost Management
por: Curtiss, Frederic R.
Publicado: (2004)

Non-Inferiority of Sutureless Aortic Valve Replacement in the TAVR Era: David versus Goliath
por: Zubarevich, Alina, et al.
Publicado: (2022)

Correction: Obscurins: Goliaths and Davids Take over Non-Muscle Tissues
por: Ackermann, Maegen A., et al.
Publicado: (2018)

David vs. Goliath: The Structure, Function, and Clinical Prospects of Antibody Fragments
por: Bates, Adam, et al.
Publicado: (2019)

Left pulmonary artery sling and COVID-19: David against Goliath
por: Renzulli, Matteo, et al.
Publicado: (2021)

David versus goliath: ACE2-Fc receptor traps as potential SARS-CoV-2 inhibitors
por: Alfaleh, Mohamed A., et al.
Publicado: (2022)

The Revival of the Battle between David and Goliath in the Enteric Viruses and Microbiota Struggle: Potential Implication for Celiac Disease
por: Lerner, Aaron, et al.
Publicado: (2019)

Goliath's Revenge
por: Hewlin, Todd
Publicado: (2019)

When David Beats Goliath: The Advantage of Large Size in Interspecific Aggressive Contests Declines over Evolutionary Time
por: Martin, Paul R., et al.
Publicado: (2014)

Microfilariae infestation of goliath frogs (Conraua goliath) from Cameroon
por: Nguete Nguiffo, Daniel, et al.
Publicado: (2019)

A Challenge to Goliath
por: Rossner, Mike
Publicado: (2009)

A challenge to Goliath
por: Rossner, Mike
Publicado: (2009)

A challenge to Goliath
por: Rossner, Mike
Publicado: (2009)

COVID-19 pandemic and non invasive respiratory management: Every Goliath needs a David. An evidence based evaluation of problems
por: Winck, J.C., et al.
Publicado: (2020)

A David and Goliath set-up: a qualitative study of the challenges of ensuring the introduction of cost-effective new cancer medicines in Finland
por: Ollila, Eeva, et al.
Publicado: (2022)

Do David and Goliath Play the Same Game? Explanation of the Abundance of Rare and Frequent Invasive Alien Plants in Urban Woodlands in Warsaw, Poland
por: Obidziński, Artur, et al.
Publicado: (2016)

David D. Derse, 1949-2009
por: Shuh, Maureen
Publicado: (2009)

Hereditary Gigantism-the biblical giant Goliath and his brothers
por: Donnelly, Deirdre E, et al.
Publicado: (2014)

Magnetic Field Measurements of the GOLIATH Magnet in EHN1
por: Rosenthal, Marcel, et al.
Publicado: (2018)

Data and Goliath: the hidden battles to capture your data and control your world
por: Schneier, Bruce
Publicado: (2015)

Invited commentary on David Fedson’s article
por: Clark, Ian, et al.
Publicado: (2009)

Niacin in Maize
por: Burkholder, Paul R., et al.
Publicado: (1944)

Harm reduction in the USA: the research perspective and an archive to David Purchase
por: Des Jarlais, Don C.
Publicado: (2017)

Goliath magnet, bldg. 887 photographed from every angle
por: Laurent Guiraud
Publicado: (1997)

Zinc Limitation Induces a Hyper-Adherent Goliath Phenotype in Candida albicans
por: Malavia, Dhara, et al.
Publicado: (2017)

Should all patients receive dual chamber pacing ICDs? The rationale for the DAVID trial
por: Wilkoff, Bruce L
Publicado: (2001)

How Mighty Are the Mitochondria in Causing Individual Differences in Intelligence?—Some Questions for David Geary
por: Sternberg, Robert J.
Publicado: (2020)

The GOLIATH Project: Towards an Internationally Harmonised Approach for Testing Metabolism Disrupting Compounds
por: Legler, Juliette, et al.
Publicado: (2020)

Design and Evaluation of Niacin Microspheres
por: Maravajhala, Vidyavathi, et al.
Publicado: (2009)

Classifying Goliath Grouper (Epinephelus itajara) Behaviors from a Novel, Multi-Sensor Tag
por: Brewster, Lauran R., et al.
Publicado: (2021)

Niacin Alternatives for Dyslipidemia: Fool’s Gold or Gold Mine? Part II: Novel Niacin Mimetics
por: Goel, Harsh, et al.
Publicado: (2016)

Niacin Alternatives for Dyslipidemia: Fool’s Gold or Gold Mine? Part I: Alternative Niacin Regimens
por: Dunbar, Richard L., et al.
Publicado: (2016)

Niacin in the Treatment of Hyperlipidemias in Light of New Clinical Trials: Has Niacin Lost its Place?
por: Zeman, Miroslav, et al.
Publicado: (2015)

How a butterfly's wing can bring down Goliath: chaos theories calculate the vulnerability of megasystems
por: Davidson, K
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_6g7sb7ubgndk8o7fhk3vt4cdu8